重组人血管内皮抑素在治疗头颈部恶性肿瘤中的(4)
[1] O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2):277-285.
[2] Mohajeri A, Sanaei S, Kiafar F, et al. The challenges of recombinant endostatin in clinical application: focus on the different expression systems and molecular bioengineering[J]. Adv Pharm Bull,2017,7(1):21-34.
[3] Zhou S, Zuo L, He X, et al. Efficacy and safety of rh-endostatin(Endostar) combined with pemetrexed/cisplatin followed by rhendostatin plus pemetrexed maintenance in non-small cell lung cancer: a retrospective comparison with standard chemotherapy[J].Thorac Cancer,2018,9(11):1354-1360.
[4] Qin RS, Zhang ZH, Zhu NP, et al. Enhanced antitumor and antiangiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma[J].BMC Cancer,2018,18(1):967.
[5] 刘书昊,潘运龙,覃莉,等.纳米金结合重组人血管内皮抑素对人脐静脉内皮细胞增殖、凋亡及迁移的影响[J].中华实验外科杂志,2018,35(4): SH, Pan YL, Qin L, et al. The effect of the gold nanoparticles combined with endostar on proliferation, apoptosis, migration of human umbilical vein endothelial cells[J]. Chin J Exp Surg, 2018,35(4):645-648.
[6] Nemoto T, Kubota S. Vascular endothelial cadherin is an endostatin receptor[J].Biologia(Bratislava),2011,66(4):721-726.
[7] Xu X, Mao W, Chen Q, et al. Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/beta-catenin signaling pathway[J]. PLoS One, 2014, 9(9):e.
[8] Zhang Q, Cao J, Xue K, et al. Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma[J].Onco Targets Ther,2016,10:145-151.
[9] Xiao L,Yang S,Hao J,et attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis[J].Cancer Lett,2015,359(1):148-154.
[10] Ning T, Jiang M, Peng Q, et al. Low-dose endostatin normalizes the structure and function of tumor vasculature and improves the delivery and anti-tumor efficacy of cytotoxic drugs in a lung cancer xenograft murine model[J]. Thorac Cancer, 2012, 3(3): 229-238.
[11] Fu W, Zhuo J, Hu L. Differential effects of recombinant human endostatin treatment on differentiated and undifferentiated blood vessels in Lewis lung cancer[J].Oncol Lett,2017,13(1):196-200.
[12] Yu M, Han Y, Zhuo H, et al. Endostar, a modified endostatin induces vascular normalization to improve chemotherapy efficacy through suppression of src signaling pathway[J]. Cancer Biother Radiopharm,2018,33(4):131-138.
[13] Li W, Zhao X, Du B, et al. Gold nanoparticle-mediated targeted delivery of recombinant human endostatin normalizes tumour vasculature and improves cancer therapy[J].Sci Rep,2016,6:.
[14] Jin T, Li B, Chen XZ. A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT0) [J]. Oncol Res,2013,21(6):317-323.
[15] Jin T, Jiang F, Jin QF, et al. Endostar combined with gemcitabine and cisplatin chemotherapy for patients with metastatic nasopharyngeal carcinoma: an update[J]. Transl Oncol, 2018, 11(2): 286-291.
[16] Chen J, Yao Q, Huang M, et al. A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01)[J].Int J Cancer,2018,142(10):2130-2138.
[17] Chen C, Liu SR, Zhou S, et al. Recombined humanized endostatin(Endostar)intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: three case reports[J]. Medicine (Baltimore).2019,98(32):e.
[18] Lu S, Li L, Luo Y, et al. A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer[J].J Thorac Oncol,2015,10(1):206-211.
[19] Chen J,Qi J,Yu B,et al.A retrospective study to compare five induction chemotherapy regimens prior to radiotherapy in the reduction of regional lymph node size in patients with nasopharyngeal carcinoma[J].Med Sci Monit,2018,24:2562-2568.
[20] Zhang K, Wang Y, Yu X, et al. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth[J].BMC Cancer,2017,17(1):899.
[21] Liu GF, Chang H, Li BT, et al. Effect of recombinant human endostatin onradiotherapy for esophagus cancer[J]. Asian Pac J Trop Med,2016,9(1):86-90.
[22] Zheng YF, Ge W, Xu HL, et al. Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model[J].Oncol Lett,2015,10(5):3067-3072.
[23] Zhang L, Ge W, Hu K, et al. Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells[J].Mol Biol Rep,2012,39(1):89-95.
[24] He L, Zhao C, Li Y, et al. Antiangiogenic effects of recombinant human endostatin in lung cancers[J]. Mol Med Rep, 2018, 17(1):79-86.
文章来源:《中国肿瘤生物治疗杂志》 网址: http://www.zgzlswzlzz.cn/qikandaodu/2020/1224/467.html